ImaGenes

Berlin, Germany Founded: 2007 • Age: 19 yrs Acquired By Source BioScience
Genome research services, including gene cloning and profiling, are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About ImaGenes

ImaGenes is a company based in Berlin (Germany) founded in 2007 was acquired by Source BioScience in December 2010. ImaGenes operates in a competitive market with competitors including Ancestry, Caribou Biosciences, Personalis, Precision Medicine Group and Novogene Corporation, among others.

  • Headquarter Berlin, Germany
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Source BioScience

    (Dec 01, 2010)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ImaGenes

Premium access

Detailed funding history for ImaGenes

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in ImaGenes

ImaGenes has secured backing from 1 investor. Prominent investors backing the company include Source BioScience.

All
Investor Description Founded Year Domain Location
Multiple genomic services are provided for analysis and diagnostics.
Locked Locked Locked
Premium access

Investor details for ImaGenes

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ImaGenes

Investments
Premium access

Investment portfolio details for ImaGenes

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ImaGenes

Premium access

Detailed financials for ImaGenes

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Imagenes Comparisons

ImaGenes Primary company
Description
Genome research services, including gene cloning and profili...
Location
Berlin, Germany
Founded Year
2007
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ImaGenes

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ImaGenes

ImaGenes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ancestry, Caribou Biosciences, Personalis, Precision Medicine Group and Novogene Corporation, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of an online genealogy platform offering a host of services
Locked Locked Locked
Provider of cell therapies to treat cancer and hematologic conditions
Locked Locked Locked
Genomic sequencing and diagnosis software is provided for healthcare.
Locked Locked Locked
Provider of clinical research, development, and commercialization services for life sciences
Locked Locked Locked
Genomic services and solutions with NGS expertise are provided.
Locked Locked Locked
Provider of genomic-based personalised pluripotent stem cell therapy
Premium access

Detailed competitors of ImaGenes

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Imagenes

Premium access

Complete news archive for ImaGenes

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ImaGenes

ImaGenes was founded in 2007.

ImaGenes is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

ImaGenes was founded in 2007 in Berlin, Germany, within the biotechnology sector. Genome research services are offered, featuring the GenomeCube search engine. Comprehensive collections of clones for mammalian and vertebrate genes are managed. Gene profiling services are conducted on Affymetrix, Agilent, and NimbleGen platforms to support various functional analyses in research operations.

ImaGenes's top competitors include Ancestry, Personalis and Novogene Corporation.

ImaGenes has 1 investor. Key investors include Source BioScience.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available